Monday, February 24, 2020

Celiac Disease Treatment Market 2019 Synopsis with Leading Players, Industry Growth Factor Foresight by 2023

According to MRFR analysis, Celiac Disease Treatment Market is expected to register a CAGR of 18.60% during the forecast period of 2019 to 2025.

Market Highlights

Celiac disease is a digestive disorder hindering the functioning of the small intestine. Celiac disease is triggered by eating foods containing gluten and is common among patients of down syndrome, Turner syndrome, and type 1 diabetes.
Rising diabetes cases, increasing prevalence of the celiac disease, favorable government policies across the Western world (the Americas and Europe), increasing number of clinical trials, raising awareness for the disease, and increasing penetration of therapeutic products in the developing economies are some of the major drivers for the global celiac disease treatment market.
However, factors such as limited availability of the treatment options and underdiagnosis/misdiagnosis of celiac disease are projected to restrain the market growth during the forecast period of 2019 to 2025.
Several market players currently dominate the global Celiac Disease Treatment Market. The key players are 
involved in product launches and strategic collaborations to strengthen their market positions.

Key Players

Some of the key players in the global celiac disease treatment market are Amgen Inc. (US), Amneal Pharmaceuticals LLC (US), BioLineRx (Israel), Calypso Biotech SA (Switzerland), Freedom Foods Group Limited (Australia), General Mills, Inc. (US), Glenmark Pharmaceuticals Inc. (India), Hain Celestial Group, Inc. (US), Innovate Biopharmaceuticals Inc. (US), Kellogg Company (US), Mondelez International Inc. (US), Mylan Pharmaceuticals Inc. (US), Pinnacle Foods, Inc. (US), Selecta Biosciences, Inc (US), Takeda Pharmaceutical Company Ltd (Japan), The Kraft Heinz Company (US), West-Ward Pharmaceutical (US), Zedira GmbH (Germany), Zydus Pharmaceuticals Inc. (US), and others.

Segmentation:

The global celiac disease treatment market has been segmented based on treatment and end-user.
The market, based on treatment, has been divided into a gluten-free diet, vitamin & mineral supplements, enzyme supplement therapy, and medications. The gluten-free diet segment has been further segmented into gluten-free bakery products, gluten-free baby food, gluten-free pasta, and gluten-free meals. The medication segment is further divided into azathioprine and budesonide. The gluten-free diet segment held the largest market share in the market in 2018.
Based on end-user, the celiac disease treatment has been divided into hospitals & clinics, clinical research organizations, and research & academic institutes. Hospitals and clinics were the largest revenue shareholder in the 
global celiac disease treatment market.

Regional Analysis:

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The 
Americas are expected to be the largest market owing to the increasing prevalence of celiac disease and rising per capita healthcare expenditure. On a regional basis, America's celiac disease treatment market has been further segmented into North America and Latin America. The North American market is further divided into the US and Canada. The European celiac disease treatment market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The celiac disease treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Increasing patient pool for diabetes and celiac disease, rapidly developing healthcare sector, and rising per capita healthcare sector enables the Asia-Pacific region to be the fastest-growing regional market for celiac treatment during the forecast period. The celiac disease treatment market in the Middle East & Africa has been divided into the Middle East and Africa.


About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Oxygen Therapy Equipment Market up to 2023: Top Companies, Growth Factors Details and Regional Overview by Types & Application

Oxygen Therapy Equipment Market: By Product (Oxygen Source Equipment, Oxygen Delivery Devices), Portability (Stationary Oxygen Therapy Devices, Portable Oxygen Therapy Devices), Application (Cystic Fibrosis, Pneumonia) — Global Forecast till 2023

Segmental Analysis:

The segmentation of the oxygen therapy equipment market has been segmented on the basis of portability, application, product, and end users. Based on the product, the oxygen therapy equipment market has been segmented into oxygen delivery devices and oxygen source equipment. The segmentation of the oxygen therapy equipment market based on portability comprises of portable oxygen therapy devices and stationary Oxygen Therapy Devices Market. Based on application, the oxygen therapy equipment market has been segmented into asthma, COPD, respiratory distress syndrome, cystic fibrosis, pneumonia, and other diseases. The end user segment of the oxygen therapy equipment market comprises of hospitals, ambulatory surgical centers, home care settings, physician offices, and others. Based on the region, the market for oxygen therapy equipment is segmented into Europe, Asia Pacific, the Middle East, the Americas, and Africa.

Competitive Analysis:

Some of the key players in the global oxygen therapy equipment market are Philips Healthcare (A Division of Koninklijke Philips N.V.), Linde Healthcare (A Division of Linde Group), Becton Dickinson and Company, Taiyo Nippon Sanso Corporation, Smiths Medical (A Division of Smiths Group PLC), Drägerwerk AG & Co. KGaA, Teleflex Incorporated, Invacare Corporation, Fisher & Paykel Healthcare Corporation Limited, Allied Healthcare Products Inc., Esex Industries, Inc., Messer Medical Austria GmbH, Medicop D.O.O

Oxygen Therapy Equipment Market Overview:

The development of procedures that can provide an increased level of preventive care is driving the demand for oxygen therapy equipment. Reports that gauge the healthcare industry have been made available by Market Research Future which creates reports on several industry verticals that review the market growth and prospects. The market is expected to register a CAGR of 8.9 % in the forecast period.
The amplified occurrence of ailments such as pneumonia, chronic obstructive pulmonary disease, and asthma is anticipated to accelerate the development of the oxygen therapy equipment market. The intensifying healthcare expenditures and advantageous reimbursement policies for oxygen therapy equipment are forecasted to motivate the growth of the market in the upcoming years.
The progress of the market is expected to capture increased momentum in the coming years primarily due to the presence of conducive government policies. The growth turnaround in the market is expected to activate new opportunities for expansion of the market. The improvements in various domestic economies are expected to motivate the development of the market in the upcoming period. The accessibility to key tactical opportunities leading to consequent stabilization of inflation is anticipated to create promising openings for expansion in the coming years. In the coming years, the influence exerted by relatively high-income levels in nations around the world and the potential gains observed to some of the currencies in the world is expected to reinforce the evolution of the market in the forecast period. A considerable rise in the number of investors in the market is projected to create an advantageous scenario for the progress of the market in the forecast period.

Detailed Regional Analysis:  

The regional evaluation of the Oxygen Therapy Equipment Market states that the Americas region is dominating the oxygen therapy equipment market due to the presence of a huge patient population for diseases like COPD, promising reimbursement policies and growing demands for home care by the growing geriatric population. Additionally, rising healthcare expenditure, the presence of developed economies like the U.S. and Canada fuel the market growth. The European market is likely to hold the second chief market share. Factors such as increasing government support for the healthcare sector, huge patient population drives the market growth within the region. While the market portion in the Asia Pacific region is also estimated to witness growth in the future owing to access to ideal treatment facilities and increasing demand for government initiatives, progressive technology, improved adoption rate, and mounting healthcare expenditure. Conversely, the Middle East and African region have a minimum stake in the oxygen therapy equipment market. This can be accredited to the incidence of deprived economies and strict government policies, particularly in the African region.


About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Near Infrared Imaging Market Value Chain, Factor Analysis, Region and Forecasts Till 2023

Near Infrared Imaging Research Report: by Product Type (Devices, Reagents, and others), by Application (Cancer Surgeries, Preclinical Imaging, and others) By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Clinic) - Global Forecast Till 2023

Market Drivers and Key Barriers

Near infrared imaging, the market is expanding at a striking pace largely due to rising cancer cases and the surge in technological advancements. Near infrared imaging helps the wildlife researchers in studying warm-blooded animals, in addition to aiding archaeologists in analyzing the artifacts as well as in surveying various archaeological sites.
World over, the development of cutting-edge and sophisticated technology, expeditious advancement of high-speed infrared cameras that come with latest features and the consistent advancement of micro bolometer has resulted in the radical transformation of the near infrared imaging market.
Other than this, the growth in the adoption rate of Near Infrared Imaging Market in the field of military and defense to detect small details over extended distances, and the rising demand from emerging nations like India and China will bring in excellent business for the market in the subsequent years.
Although the market growth is expected to be excellent in the future, the market could hit a roadblock in the form of high cost of research and development. But, the boost in the number of surgical procedures and the rising prevalence of chronic diseases and expanding geriatric population are projected to be propitious factors in the market growth in the foreseeable future.

Prominent Vendors:

The prominent vendors part of the global near infrared imaging market include Leica Microsystems (Germany), Mizuho Medical Co., Ltd. (Japan), Quest Medical Imaging B.V. (the Netherlands), PerkinElmer Inc. (US), Stryker Corporation (US), Hamamatsu Photonics K.K., (Japan), Karl Storz Se & Co.Kg (Germany), Shimadzu Corporation (Japan), Olympus Corporation (Japan), Medtronic (Ireland), Li-Cor Inc. (US), Carl Zeiss Meditec AG (Germany), and others.

Market Segmentation:

The worldwide near infrared imaging market has been segmented on the basis of product type, application, and end user.
The types of products mentioned in the report are devices, reagents, and others. The devices segment is sub-segmented into near-infrared fluorescence imaging systems and near-infrared bioluminescence imaging systems.
In terms of application, the market is considered for cancer surgeries, preclinical imaging, plastic/reconstructive surgeries, gastrointestinal surgeries, cardiovascular surgeries, and others.
The near infrared imaging market, depending on the end-user, caters to pharmaceutical & biotechnology companies, hospitals & clinics, research laboratories & academic institutions, and others.

Recent Developments:

June 2019: A team of researchers from Denmark has developed a method that helps translate information from the mid-infrared (MIR) area with most distinct chemical signatures to the near-infrared (NIR) region with most sensitive existing camera technology. This system has the ability to capture the MIR spectral images of dynamic processes happening in just a few milliseconds. This technology also helps in investigating the chemical signatures of cancer as well as various other diseases with high accuracy.

Regional Analysis:

The global near infrared imaging market is spread across the prominent regions of Europe, Asia Pacific, America, and the Middle East & Africa.
America is expected to gain massive prominence in the global near infrared imaging market, says MRFR. The dominance of the region is the result of the high spending on healthcare, expanding geriatric population, rising prevalence of target diseases, a growing number of cosmetic surgeries, and the fast-track adoption of technologically sophisticated imaging systems within the region.
Accumulating the second-largest share of the global near infrared imaging market, Europe’s growth trajectory is expected to be striking in the near future, owing to the existence of a strong academic & research base coupled with the massive funding for research in the region. Case in point is the European Research Council (ERC), which is known for providing grants for scientific research within the European Union (EU). The booming medical tourism in the region, high awareness level, and huge foreign investments for research and development are presumed to do wonders for the regional market in the ensuing years.
The Asia Pacific market for near infrared imaging thrives with considerable contributions from countries like India, Japan, China, Republic of Korea, Australia and the Rest of Asia Pacific. The region is speculated to be growing at the fastest-rate backed by the increasing focus by the government on biomedical and biotechnology sector paired with the elevated number of target population within the region. Moreover, technological advancements, along with the integration of information technology (IT) in the healthcare industry, have been the high impact rendering factors fueling the market growth in the region.
Finally, the growth of the Middle East & Africa market has been unsatisfactory, accounting for the least share of the worldwide near infrared imaging market. The major portion of the regional market is expected to be under the Middle East region, with the primary deciding factor being the rise in the government initiatives with the aim of improving the healthcare sector in the region.


About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Interventional Neurology Market up to 2023: Top Companies, Growth Factors Details and Regional Overview by Types & Application

Interventional Neurology Market Research Report: By Disease Pathology (Cerebral Aneurysms, Ischemic Strokes, & Others), Product (Aneurysm Coiling & Embolization, Neurothrombectomy, Support Devices, & Others), End User – Global Forecast Till 2023

Worldwide Key Players

Some of the key players in the global Interventional Neurology Market are Abbott Laboratories, Johnson & Johnson, Boston Scientific Corporation, Stryker Corporation, Medtronic PLC, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Merit Medical Systems, Inc., W.L. Gore & Associates, Inc., B. Braun Melsungen AG, Cook Medical, and others.

Interventional Neurology Market - Highlights

The Global interventional neurology market is expected to grow at an approximate CAGR of 7.8% during forecast period, 2018–2023.
Increasing participation of market players is the key factor driving the interventional neurology market. For instance, in 2018, Rapid Medical announced CE Mark approval in the European Union for its Tigertriever 13 stent retriever for the treatment of ischemic stroke.
Various other factors such as technological advancements, presence of a large target patient population, favourable medical reimbursements and growing demand for effective neurovascular devices are also expected to propel the growth of the market.
However, lack of skilled neurosurgeons and stringent regulations can hinder the market growth over the forecast period.

Segmentation Analysis

The Global interventional neurology market is segmented based on disease pathology, product, end user and region.
The Global market for interventional neurology, by disease pathology is segmented into cerebral aneurysms, arteriovenous malformation and fistulas, ischemic strokes, and others.
The market, by product, is segmented into aneurysm coiling & embolization devices, cerebral balloon angioplasty and stenting systems, neurothrombectomy devices, and support devices. The aneurysm coiling & embolization devices segment is further classified as embolic coils, flow diversion devices, and liquid embolic agents. The embolic coils segment includes bare detachable coils and coated detachable coils. The cerebral balloon angioplasty and stenting systems segment is further classified as carotid artery stents, and embolic protection systems. The embolic protection systems segment includes distal filter devices, and balloon occlusion devices. The neurothrombectomy devices are further classified as clot retrieval devices, suction and aspiration devices, and snares. The support devices are further classified as microcatheters, and microguidewires.
Based on end user, the market is segmented into hospitals & clinics, ambulatory surgical centers, research & academic institutes, and others.

Regional Analysis

The Americas dominated the global market for interventional neurology owing to presence of major market players and rising geriatric population.
In 2017, it was estimated that Europe stood second in the global interventional neurology market. This can be attributed to the rising research and development investments.
Asia Pacific was projected to be the fastest growing region in 2017. Factors such as growing healthcare sector, increasing penetration of the market players within the region, and increasing healthcare expenditure drives the regional markets of the Asia Pacific region.
On the other hand, the Middle East and Africa held least share in the global interventional neurology market due to the low per capita income, especially within the African region. The growth in this region is attributed to the rising cases neurological conditions. The burden of neurological disorders in African region has been increasing over the years. The annual incidence of stroke has been estimated to be 316 per 100 000 in Africa.


About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Compression Therapy Market Overview by Trends, Industry Top Manufactures, Size, Industry Growth Analysis & Forecast till 2023

Compression Therapy Market Research Report: By Technique (Static and Dynamic), Product (Compression Garments, Compression Pump, Compression Braces), Application (Varicose Vein, Deep Vein Thrombosis, Lymphedema, Leg Ulcer) – Global Forecast Till 2023

Compression Therapy Market Highlights:

The Global Compression Therapy Market is expected to grow at an approximate CAGR of 5.2% during forecast period, 2018–2023.
Increasing participation of market players is the key factor driving the compression therapy market. For instance, in 2015, SIGVARIS launched diabetic compression socks to provide maximum therapeutic relief for diabetic patients.
Various other factors such as increasing incidence of sports injuries and accidents, technological advancements, presence of a large target patient population and rising patient awareness regarding the benefits of compression therapy are also expected to propel the growth of the market.
However, low patient compliance for compression garments, adoption of alternative therapies for specific target indications and lack of universally accepted standards for compression products can hinder the market growth over the forecast period.

Segmentation Analysis:

The Global compression therapy market is segmented based on technique, product, application and region.
The Global market for compression therapy, by technique is segmented into static compression therapy and dynamic compression therapy.
The market, by product, is segmented into compression garments, compression pumps and compression braces. The compression garments segment is further classified as compression stockings, compression bandages & wraps and others.
Based on application, the market is segmented into varicose vein treatment, deep vein thrombosis treatment, lymphedema treatment, leg ulcer treatment and others.

Competitive Players:

Some of the key players in the global compression therapy market are 3M, Medtronic PLC, Bio Compression Systems, Inc., BSN Medical, Medi GmbH & Co. Kg, Paul Hartmann AG, Smith & Nephew PLC., Cardinal Health, Inc., Sigvaris, Sanyleg S.R.L., Tactile Medical, Convatec Inc., DJO Global Inc., Getinge AB, Juzo and others.

Regional Analysis:

The Americas dominated the global market for compression therapy. This can be attributed to the presence of major market players within the region.
Owing to the rising research and development investment and increasing prevalence venous leg ulcers, European compression therapy market stood second in 2017. According to the 2018 study published in the Burns & Trauma journal, venous ulcers are a common chronic problem in many countries especially in Northern Europe. The overall prevalence of this condition is 1%-3% in the population above 65 years of age.
Asia Pacific was projected to be the fastest growing region in 2017. Factors such as growing healthcare sector, increasing penetration of the market players within the region, and increasing healthcare expenditure drives the regional markets of the Asia Pacific region. According to the data suggested by the Australian Institute of Health and Welfare, Australia spent nearly USD 181 billion on health in 2016–2017.
On the other hand, the Middle East and Africa held least share in the global compression therapy market due to the low per capita income, especially within the African region.


About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028   
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Medical Case Management Market Value Chain, Factor Analysis, Region and Forecasts Till 2023

Medical Case Management Market Research Report: by Mode Type (Web-based Case Management, Telephonic Case Management, Field Case Management, Bilingual Field Case Management), Case Type (Chronic Pain Case Management), End User - Global Forecast Till 2023

Market Highlights:

The Global Medical Case Management Market held a market value of USD 4,379.3 million in 2017 and is projected to grow at a CAGR of 4.3% over the forecast period. Medical case management is a collective process that allows recommended treatment plans to ensure suitable medical care is offered to disabled, ill or injured individuals. These services are provided under the direction of, or by referral from a clinical provider and encompass client-centered services that implement the clinical treatment plan, including linking clients with healthcare, psychosocial, and other services. Case management helps in controlling costs and improving the quality of health and social service delivery. Few of the major market growth factors are the presence of government initiatives & regulations to promote patient-centric care, rising initiatives to shift the burden of risk from healthcare payers to providers, growing need to curtail healthcare-associated costs, increasing need for improved quality of care, and booming healthcare IT sector.

Key Players:

Some of the major players in the global medical case management market are Medical Case Management Group, Axiom Medical Consulting, LLC, Genex Services, LLC, EK Health, Inc., EagleOne Case Management Solutions, Inc., Europ Assistance - Global Corporate Solutions, Managed Medical Review Organization, Inc., CompAlliance, Prime Health Services, Inc., Sierra Nevada Administrators, GMMI, Inc., and Global Excel Management Inc.

Segmentation:

The Global Medical Case Management Market has been mainly segmented into mode type, case type, and end user.
By mode type, the market has been divided into web-based case management, telephonic case management, field case management, bilingual field case management, and others. On the basis of case type, the market has been segmented into chronic pain case management, catastrophic case management, independent medical examinations, short-term disability, long-term disability, and others. Based on end user, the market has been categorized into hospitals, home care settings, and others.

Regional Analysis:

The Global Medical Case Management Market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. On the basis of region, the Americas is expected to dominate the global medical case management market. This is due to changing shift towards curbing of healthcare costs, the presence of associations, namely, the American Case Management Association (ACMA), Commission for Case Manager Certification (CCMC), American Association of Healthcare Administrative Management (AAHAM), and large number of major market value contributors headquartered in the region.
Europe will follow Americas in terms of value during the forecast period attributed to rising prevalence of chronic diseases along with rising adoption of medical case management for long-term and acute medical care in the region. For instance, According to European Heart Network, 9 out of 10 people die from the chronic disease in Europe and the region is paying heavy price for chronic diseases. Chronic diseases are the leading cause of mortality in Europe, representing 77.0% of the total disease burden and 86.0% of all deaths.
The market in Asia-Pacific is anticipated to exhibit comparatively higher CAGR during the forecast period owing to growing population in India and China, and growing partnerships between healthcare insurance providers and medical services providers. Personal medical case management (PMCM) is currently helping to bridge the gaps in healthcare, thereby expected to nurture the market growth.
The Middle East & Africa has the least share of the global medical case management market. Additionally, the major market share of the region would be held by the Middle East region due to improving quality healthcare in the Middle East.


About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Fabry Disease Market Leading Key Players, Drivers, Revenue, Demand, Analysis and Forecasts to 2023

The Global Fabry Disease Market is Expected to Exhibit a Strong 6.8% CAGR Over the Forecast Period from 2019 to 2023, According to the Latest Research Report from Market Research Future (MRFR).

Fabry Disease Market – Highlights & Overview

The global Fabry disease market is profiled in detail in the report, taking into account the market’s historical trajectory as well as major drivers and restraints. The major drivers and restraints affecting the global Fabry Disease Market are profiled in detail in the report in order to provide readers with a complete overview of the market’s likely growth patterns in the coming years. Leading players operating in the global Fabry disease market are also profiled in the report.
Fabry disease is an inherited X-linked disorder affecting the enzymes that process biomolecules known as sphingolipids. This leads to an inability to process sphingolipids, causing the latter to build up in various body organs and blood vessels. Fabry disease primarily affects the skin, heart, and kidneys. It is mainly treated through enzyme replacement therapies, as they have proven to be an effective barrier to the progression of Fabry disease. Increasing sophistication in the development of synthetic and bio-identical enzymes for use in medicine is likely to be a major driver for the global Fabry disease market over the forecast period.
Extensive research and development aimed at curing Fabry disease is likely to be a major driver for the Fabry disease market over the forecast period. Drug development in the Fabry disease market has picked up pace in recent years, with Amicus Therapeutics launching Galafold capsules 123 mg in May 2018 and Protalix’s pegunigalsidase alfa undergoing phase 3 clinical trials, to name a few. The increasing research into genetic therapies is also likely to be a major driver for the global Fabry disease market over the forecast period. As Fabry disease is a genetic disease, there is strong potential for advances in the field of genetics to cure the disease effectively. This has driven strong research and development efforts in the field of Fabry disease in the last few years. This is likely to remain a major driver for the Fabry disease market over the forecast period.

Competitive Analysis:

Leading players in the global Fabry disease market include Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Shire, Sanofi, Protalix, Idorsia Pharmaceuticals Ltd., AVROBIO Inc., Pfizer Inc., Novartis AG, Neuraltus Pharmaceuticals Inc., iBio Inc., GSK plc, Bristol-Myers Squibb Company, Amicus Therapeutics Inc., and Amgen Inc.

In November 2019, Protalix and Chiesi received the green light from the FDA to seek accelerated approval of PRX-102, an investigational enzyme replacement therapy, for the treatment of Fabry disease.

Segmentation:

The global Fabry disease market is segmented on the basis of type, diagnosis, treatment, end use, and region.
By type, the global Fabry disease market is segmented into type 1 and type 2.
By diagnosis, the global Fabry disease market is segmented into blood test, urine test, thyroid test, lung function test, imaging, hearing and eye examination, and others. The imaging segment is further subclassified as electrocardiogram, echocardiogram, brain MRI, CT, and others.
By treatment, the global Fabry disease market is segmented into enzyme replacement therapy, gene therapy, pharmaceutical formulations containing agalsidase alfa, analgesics, anticonvulsants, nonsteroidal anti-inflammatory drugs, and others.
By end use, the global Fabry disease market is segmented into hospitals and clinics, diagnostic centers, research and academic institutes, and others.

Regional Analysis:

The Americas is expected to dominate the global Fabry disease market, followed by Europe. Rising healthcare expenditure and rising awareness about the condition are the major drivers for the Fabry disease market in the Americas, especially North America. Fabry disease is a genetic condition. As such, the regional leaderboard for the Fabry disease market is dominated by regions where genetics studies have progressed at a strong rate and the field of genetic therapies and enzyme replacement has advanced sufficiently to be accessible for the population. In Asia Pacific, the high costs of enzyme replacement therapy have kept the market down in the past.


About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked 
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028   
Maharashtra, India
Phone: +1 646 845 9312
at No comments:
Subscribe to: Posts (Atom)

Growth Hormone Deficiency Market 2022 Estimation and Forecasts up to 2027

  Growth Hormone Deficiency Market Growth hormone deficiency also called pituitary dwarfism or simply dwarfism, refers to a condition result...